2024
Multicenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 Patients.
Ayyagari R, Rahman S, Grizzard K, Mustafa A, Staib L, Makkia R, Bhatia S, Bilhim T, Carnevale F, Davis C, Fischman A, Isaacson A, McClure T, McWilliams J, Nutting C, Richardson A, Salem R, Sapoval M, Yu H. Multicenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 Patients. Radiology 2024, 310: e231877. PMID: 38441098, DOI: 10.1148/radiol.231877.Peer-Reviewed Original ResearchConceptsProstatic artery embolizationCumulative air kermaRadiation-related adverse eventsBody mass indexAdverse eventsEffective doseFluoroscopy timeArtery embolizationRadiation doseKerma area product valuesMedian cumulative air kermaMedian effective radiation doseFluoroscopy unitPatient body mass indexRadiation exposureTwo-sample <i>t</i> test wasRadiation dose dataBenign prostatic hyperplasiaFluoroscopy-guided proceduresPatient radiation exposureEffective radiation doseRadiation field areaRadiation effective doseWilcoxon rank sum testInvasive angiographic procedures
2022
MP01-04 LONG-TERM GROSS HEMATURIA IMPROVEMENTS AFTER PROSTATIC ARTERY EMBOLIZATION: COMPARING RESULTS IN GLAND VOLUMES OF ≤80 ML VERSUS >80 ML
Rahman S, Powell T, Staib L, Ayyagari R. MP01-04 LONG-TERM GROSS HEMATURIA IMPROVEMENTS AFTER PROSTATIC ARTERY EMBOLIZATION: COMPARING RESULTS IN GLAND VOLUMES OF ≤80 ML VERSUS >80 ML. Journal Of Urology 2022, 207: e2. DOI: 10.1097/ju.0000000000002513.04.Peer-Reviewed Original ResearchProstatic artery embolization
2019
Prostatic Artery Embolization Using 100–300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up
Ayyagari R, Powell T, Staib L, Chapiro J, Raja A, Bhatia S, Chai T, Schoenberger S, Devito R. Prostatic Artery Embolization Using 100–300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up. Journal Of Vascular And Interventional Radiology 2019, 31: 99-107. PMID: 31771896, DOI: 10.1016/j.jvir.2019.08.005.Peer-Reviewed Original ResearchMeSH KeywordsAcrylic ResinsAge FactorsAgedAged, 80 and overComorbidityCone-Beam Computed TomographyConnecticutEmbolization, TherapeuticGelatinHumansLower Urinary Tract SymptomsMaleMiddle AgedOrgan SizeParticle SizeProstateProstatic HyperplasiaQuality of LifeRecovery of FunctionRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeConceptsInternational Prostate Symptom ScoreLower urinary tract symptomsPost-void residualCharlson Comorbidity IndexProstatic artery embolizationProstate gland volumeMedian lobe enlargementBenign prostatic hyperplasiaTrisacryl gelatin microspheresArtery embolizationProstatic hyperplasiaGland volumeAdverse event recordingMedical therapy failureClavien-Dindo classificationProstate Symptom ScoreMedium-term followUrinary tract symptomsLower urinary tractMedium-term outcomesPost-procedure valuesQuality of lifeComorbidity indexTract symptomsConsecutive patientsProstatic Artery Embolization in Nonindex Benign Prostatic Hyperplasia Patients: Single-center Outcomes for Urinary Retention and Gross Prostatic Hematuria
Ayyagari R, Powell T, Staib L, Chapiro J, Perez-Lozada JC, Bhatia S, Chai T, Schoenberger S, Devito R. Prostatic Artery Embolization in Nonindex Benign Prostatic Hyperplasia Patients: Single-center Outcomes for Urinary Retention and Gross Prostatic Hematuria. Urology 2019, 136: 212-217. PMID: 31734349, DOI: 10.1016/j.urology.2019.11.003.Peer-Reviewed Original ResearchConceptsProstatic artery embolizationBenign prostatic hyperplasia patientsProstatic hyperplasia patientsInternational Prostate Symptom ScoreProstatic hematuriaHyperplasia patientsUrinary retentionArtery embolizationPostvoid residualHematuria patientsSingle-center outcomesUrinary retention patientsClavien-Dindo classificationProstate Symptom ScoreQuality of lifeTransfusion rateGross hematuriaSH patientsUrinary infectionBladder irrigationGH patientsSymptom scoresUR patientsBladder tumorsDurable treatmentCase-Control Comparison of Conventional End-Hole versus Balloon-Occlusion Microcatheter Prostatic Artery Embolization for Treatment of Symptomatic Benign Prostatic Hyperplasia
Ayyagari R, Powell T, Staib L, Chapiro J, Schoenberger S, Devito R, Pollak J. Case-Control Comparison of Conventional End-Hole versus Balloon-Occlusion Microcatheter Prostatic Artery Embolization for Treatment of Symptomatic Benign Prostatic Hyperplasia. Journal Of Vascular And Interventional Radiology 2019, 30: 1459-1470. PMID: 31375451, DOI: 10.1016/j.jvir.2019.05.033.Peer-Reviewed Original ResearchConceptsProstatic artery embolizationBenign prostatic hyperplasiaEH groupArtery embolizationSymptomatic improvementAdverse eventsProstatic hyperplasiaInternational Prostate Symptom Score improvementTrial successSymptomatic benign prostatic hyperplasiaBO groupContrast material useProstatic artery anatomySymptom score improvementAdverse event ratesProcedural metricsResidual improvementCase-control comparisonClinical improvementRetrospective reviewArtery anatomyMicrocatheter selectionContrast materialScore improvementEvent rates